INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 111 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2014. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $120,000 | -29.8% | 13,506 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $171,000 | +20.4% | 13,506 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $142,000 | +1.4% | 13,506 | -11.0% | 0.00% | 0.0% |
| Q4 2016 | $140,000 | -21.8% | 15,183 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $179,000 | -8.7% | 15,183 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $196,000 | -19.3% | 15,183 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $243,000 | -45.1% | 15,183 | -1.9% | 0.00% | -50.0% |
| Q4 2015 | $443,000 | -80.0% | 15,472 | -80.1% | 0.00% | -80.0% |
| Q3 2015 | $2,214,000 | +303.3% | 77,777 | +409.1% | 0.01% | +400.0% |
| Q2 2015 | $549,000 | +28.9% | 15,277 | +108.2% | 0.00% | 0.0% |
| Q1 2015 | $426,000 | +33.1% | 7,336 | -3.3% | 0.00% | +100.0% |
| Q4 2014 | $320,000 | +7.0% | 7,587 | -1.6% | 0.00% | 0.0% |
| Q3 2014 | $299,000 | +24.6% | 7,707 | +0.3% | 0.00% | 0.0% |
| Q2 2014 | $240,000 | -1.6% | 7,685 | +30.4% | 0.00% | 0.0% |
| Q1 2014 | $244,000 | +60.5% | 5,895 | +50.0% | 0.00% | 0.0% |
| Q4 2013 | $152,000 | +7.8% | 3,930 | -2.5% | 0.00% | 0.0% |
| Q3 2013 | $141,000 | -84.0% | 4,031 | -93.7% | 0.00% | -80.0% |
| Q2 2013 | $882,000 | – | 63,728 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 105 | $0 | 0.00% |
| Sterling Investment Advisors, Ltd. | 250 | $0 | 0.00% |
| Front Row Advisors LLC | 60 | $0 | 0.00% |
| Executive Wealth Management, LLC | 20 | $0 | 0.00% |
| BARCLAYS PLC | 1,300 | $0 | 0.00% |
| BARCLAYS PLC | 33,172 | $10,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Financial Gravity Asset Management, Inc. | 50 | $0 | 0.00% |
| Vectors Research Management, LLC | 505 | $0 | 0.00% |